December 9, 2025

NTRK and Lung Cancer – American Lung Association

December 9, 2025

PD-L1, PD1, TMB and Lung Cancer – American Lung Association

December 9, 2025

HER2-low and ultralow expression of invasive breast carcinoma: clinicopathological features and immunohistochemical consistency analysis – Nature

December 9, 2025

EGFR and Lung Cancer – American Lung Association

December 9, 2025

ASH Annual Meeting 2025 Day 3: Novel Antibody Therapies for High-Risk and Relapsed/Refractory Disease

For the last day of ASH, we’re taking a final look at some of the most exciting findings shared during Sunday’s sessions as well as late-breaking abstracts from this morning that highlight where myeloma research is headed next. Whether by investigating new regimens with already-approved treatments, or by developing unique, novel immunotherapies, the studies featured […]